Cited by 1,004Angiogenesis and VEGF in CancerLymphatic System and DiseasesFibroblast Growth Factor Research

Clinical applications of angiogenic growth factors and their inhibitors

Ferrara, Napoleone, Alitalo, Kari·1999·Nature Medicine

Abstract

Promoting the formation of new collateral vessels in ischemic tissues using angiogenic growth factors (therapeutic angiogenesis) is a an exciting frontier of cardiovascular medicine. Conversely, inhibition of the action of key regulators of angiogenesis, such as VEGF, constitutes a promising approach for the treatment of solid tumors and intraocular neovascular syndromes. These concepts are being tested now in clinical trials.

Integrity signals

Registry

Crossref · 10.1038/70928

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In 1939, Gordon and colleagues observed in rabbit grafts that tumor growth was accompanied by rapid and extensive formation of new blood vessels.

    “In 1939, Gordon and colleagues studied the relationship between tumor growth and blood supply in rabbit grafts, and they observed that tumor growth was accompanied by the rapid and extensive formation of new blood vessels.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ferrara, N., & Alitalo, K.
Affiliations
  • Genentech (US)
  • University of Helsinki (FI)
Corresponding author
  • Ferrara, Napoleone
  • Alitalo, Kari
Venue
Nature Medicine
Published
1999-12
Volume
5
Issue
12
Pages
1359-1364
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W1762724222
Cited by
1,004
References
99
Citations by year
2026: 3 · 2025: 7 · 2024: 12 · 2023: 7 · 2022: 9 · 2021: 19 · 2020: 15 · 2019: 13 · 2018: 18 · 2017: 19 · 2016: 18 · 2015: 29 · 2014: 27 · 2013: 35 · 2012: 34
FWCI
5.69
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Keywords
angiogenic factors, therapeutic angiogenesis, VEGF inhibition, angiogenesis inhibitors, collateral vessel formation, ischemic tissue, solid tumors, intraocular neovascularization, clinical trials
MeSH terms
Animals, Coronary Disease, Growth Inhibitors, Humans, Ischemia, Lymphokines, Neoplasms, Experimental, Neovascularization, Pathologic, Recombinant Proteins, Retinal Vein, Endothelial Growth Factors, Mice, Knockout, Neovascularization, Physiologic, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review